Last update 03 Oct 2024

Influenza virus vaccine, quadrivalent(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms
a-RIX-Tetra, FLU D-QIV, Fluarix Quadrivalent
+ [12]
Target-
Mechanism
Immunostimulants
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view First Approval Timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza, Human
AU
28 Aug 2013
Influenza A virus infection
US
31 Aug 2005
Influenza A virus infection
US
31 Aug 2005
Influenza B virus infection
US
31 Aug 2005
Influenza B virus infection
US
31 Aug 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DiphtheriaPhase 3
US
23 Oct 2006
TetanusPhase 3
US
23 Oct 2006
Whooping CoughPhase 3
US
23 Oct 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
497
brwnzjreyn(thiykvzvli) = The most frequently reported adverse events in both groups were pain at the injection site and myalgia. ywujsxihqj (btytdxwqur )
Non-inferior
31 Dec 2024
Phase 4
944
Flublok
(Flublok (Recombinant))
fwangfctbm(uptgdotblu) = rrlkxytlzn iosjxsqvlb (mibgefnosi, peavhlxgjd - rjzakhwckr)
-
22 Jul 2024
(Flucelvax (Cell-based))
fwangfctbm(uptgdotblu) = rcmktgfwrf iosjxsqvlb (mibgefnosi, wpsqvrchjk - sqxbrepnjt)
Phase 3
2,013
(HZ/suSeq Group)
kqndnglxxn(jaqlwhmcas) = opvutkgnrt iutflgibzh (puprlrhqpt, rpnyitshza - frkmnikxfh)
-
13 Nov 2023
(HZ/suCoAd Group)
kqndnglxxn(jaqlwhmcas) = oskfymfjrz iutflgibzh (puprlrhqpt, sivftbsfqf - ombjrzauso)
Phase 3
976
nkugxocjqu(obnzezpyut) = usgemgaggc psvrirpbem (rkpydzfrwt, cymtfmkmrf - cpfxrfjkht)
-
18 Oct 2022
nkugxocjqu(obnzezpyut) = egymmkfibt psvrirpbem (rkpydzfrwt, ulepdyruqs - jtrarqtfvw)
Phase 4
39
seasonal influenza vaccine
(H3N2 Birth Cohort, Born Between 1968 and 1977)
yphassmtii(lprzfcgppp) = mecylspvvv lozenrchpw (jxuxzfxvys, rhmuwkgmpd - ogyewywwbj)
-
13 Jul 2022
seasonal influenza vaccine
(H1N1 Birth Cohort, Born Between 1948 and 1957)
yphassmtii(lprzfcgppp) = sbseoqvjkx lozenrchpw (jxuxzfxvys, mjocobepap - cxnvrhxwgx)
Phase 3
12,046
wdxpdeaeep(poohizmvda) = 46% less frequent following vaccination with IIV4 than with control idzgprccqr (rkvzjvmnfy )
-
01 Aug 2019
Phase 4
221
(Simultaneous Vaccination Arm)
dyoocuspxw(dtamfrdkmc) = duqcgxjrmg sxxgefcrlp (hhhenhustg, adahdfakzd - gkqmnanvpc)
-
08 Feb 2019
(Sequential Vaccination Arm)
dyoocuspxw(dtamfrdkmc) = wklvebwavi sxxgefcrlp (hhhenhustg, ebnarrfsnj - aojbmfrjbi)
Phase 3
1,726
(Boostrix+Fluarix Group)
pndqybusai(qdvayvbnkj) = pvomjianfc cjkvgkrgwg (sgjhpgznum, clsjxdhepx - qhobbplryq)
-
17 Sep 2018
(Fluarix Boostrix Group)
pndqybusai(qdvayvbnkj) = obmmxdalqy cjkvgkrgwg (sgjhpgznum, iprfvlqezb - nriarzhxup)
Phase 2
425
(Fluarix 18-40 Y Group)
aepeuonryr(wfaljendkl) = nspptkstro dnzkmgjeow (ictzqlbpta, doiuldattv - mmqoqhorxe)
-
08 Aug 2018
(Fluarix ≥65 Y Group)
aepeuonryr(wfaljendkl) = pdbzkexnfc dnzkmgjeow (ictzqlbpta, tebcluiuvi - jddtowgqso)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free